Paris, France

Pierre Mangeney


Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1981-1982

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Pierre Mangeney: Innovator in Chemical Compounds

Introduction

Pierre Mangeney is a notable inventor based in Paris, France. He has made significant contributions to the field of chemistry, particularly in the development of new chemical compounds that have potential applications in medicine. With a total of 3 patents to his name, Mangeney's work is paving the way for advancements in drug development.

Latest Patents

Mangeney's latest patents include a class of seco bis-indolic compounds that can be utilized as drugs. These compounds are characterized by a specific formula, where various radicals can represent different chemical structures. Additionally, he has developed bis-indole compounds that exhibit antitumoral activity, which also correspond to a defined formula. These innovations highlight his focus on creating compounds that can serve as effective medicaments.

Career Highlights

Pierre Mangeney is associated with the Agence Nationale De Valorisation De La Recherche (ANVAR), where he continues to engage in research and development. His work is instrumental in exploring the therapeutic potential of new chemical entities. Mangeney's dedication to innovation in the field of chemistry is evident through his patent filings and ongoing research efforts.

Collaborations

Mangeney has collaborated with notable colleagues, including Nicole Langlois and Yves Langlois. These partnerships have likely contributed to the depth and breadth of his research endeavors.

Conclusion

In summary, Pierre Mangeney is a distinguished inventor whose work in chemical compounds is making a significant impact in the field of medicine. His innovative patents and collaborations reflect his commitment to advancing drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…